Akari Therapeutics PLC (AKTX) — Strategic Asset Allocation Index
Akari Therapeutics PLC (AKTX) has a Strategic Asset Allocation Index of 0.1% as of March 2020. Strategic assets (PP&E of $2.10K plus long-term investments of $-) total $2.10K, measured against net assets of $1.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See AKTX equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Akari Therapeutics PLC Strategic Asset Allocation Index (2014–2019)
This chart shows how Akari Therapeutics PLC's Strategic Asset Allocation Index has evolved across 6 annual periods from 2014 to 2019. As of March 2020, the index stands at 0.1%, representing strategic assets of $2.10K against net assets of $1.82 Million USD. For live market cap and overall valuation, see Akari Therapeutics PLC (AKTX) market capitalisation.
Annual Strategic Asset Allocation Index for Akari Therapeutics PLC (2014–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for Akari Therapeutics PLC from 2014 to 2019, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See AKTX total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 0.1% | $5.01K | $5.01K | $- | $3.84 Million | ▼ 0.0 pp |
| 2018 | 0.2% | $20.43K | $20.43K | $- | $13.38 Million | ▼ -0.1 pp |
| 2017 | 0.3% | $55.90K | $55.90K | $- | $19.98 Million | ▲ +0.1 pp |
| 2016 | 0.2% | $58.36K | $58.36K | $- | $34.10 Million | ▲ +0.1 pp |
| 2015 | 0.1% | $40.51K | $40.51K | $- | $48.72 Million | ▲ +0.1 pp |
| 2014 | 0.0% | $0.00 | $0.00 | $- | $4.85 Million | — |